Sensyne

Sensyne Health is at an important inflexion point not fully understood by the market, according to the company’s broker, Liberum, which has provided updated analysis of the med-tech firm’s prospects. ‘Looking ahead, the group is well placed to accelerate its commercialisation plans through the three partnerships it struck within its discovery science division and the … Read more